Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Europe Ear-Based Hearing Aids Market by Type (In-The-Ear Aids, Receiver-In-The-Ear Aids, Behind-The-Ear Aids, Canal Hearing Aids), by Technology (Digital Hearing Aids, Analog Hearing Aids), by Type (Sensorineural Hearing Loss, Conductive Hearing Loss) and by End User (Hospitals Clinics, Home Settings, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03488

Pages: NA

Charts: NA

Tables: NA

Ear-based hearing aids is an electronic device designed to improve hearing or restore hearing in patients who suffer from temporary or permanent hearing loss. These devices are capable of making sounds that are more accessible.

The major factors that contribute to the growth of the Europe ear-based hearing aids market include increasing prevalence of hearing disorders & hearing loss, rising aging population, technological developments in hearing care devices such as wireless devices, and increased demand for aesthetic designs of the devices. However, high costs of these devices and limited reimbursements are expected to hamper the market growth. Rise in the adoption of technically advanced hearing care devices, increasing awareness, and development in healthcare infrastructure are expected to provide numerous opportunities for the market growth during the forecast period.

The Europe ear-based hearing aids market is segmented on the basis of type, technology, type of hearing loss, end user, and country. On the basis of type, the market is segmented into in-the-ear aids (ITE), behind-the-ear aids (BTE), receiver-in-the-ear aids (RITE), and canal hearing aids. Canal hearing aids is further segmented into in-the-canal (ITC), invisible-in-canal (IIC), and completely-in-canal (CIC). Based on the type of hearing loss, the market is segmented into digital and analog hearing aids. Based on method the market is segmented into sensorineural and conductive hearing loss. According to end user, the market is divided into hospitals & clinics, home settings, and ambulatory surgical centers. By country, the market is segmented into Germany, UK, France, Italy, Spain, and rest of Europe.

The key players that operate in this market include Amplifon, Cochlear Ltd., GN Store Nord A/S, IntriCon Corporation, MED-EL, Sivantos Pte. Ltd., Sonova, Starkey, Knowles Electronics, LLC, and William Demant Holding A/S.

Key Benefits

  • The study provides an in-depth analysis of the Europe ear-based hearing aids market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the Europe ear-based hearing aids market from 2016 to 2023, which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the Europe ear-based hearing aids market has been provided.
  • Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a regional scale have been provided.
  • Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the Europe ear-based hearing aids market.

Europe Ear-based Hearing Aids Market Key Segments:

By Type

  • In-The-Ear Aids (ITE)
  • Receiver-In-The-Ear Aids (RITE)
  • Behind-The-Ear Aids (BTE)
  • Canal Hearing Aids
    • In-The-Canal (ITC)
    • Invisible-In-Canal (IIC)
    • Completely-In-Canal (CIC)

By Technology

  • Digital Hearing Aids
  • Analog Hearing Aids

By Type of Hearing Loss

  • Sensorineural Hearing Loss
  • Conductive Hearing Loss

By End User

  • Hospitals & Clinics
  • Home Settings
  • Ambulatory Surgical Centers

By Country

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

 Key Market Segments

  • By Type
    • In-The-Ear Aids
    • Receiver-In-The-Ear Aids
    • Behind-The-Ear Aids
    • Canal Hearing Aids
  • By Technology
    • Digital Hearing Aids
    • Analog Hearing Aids
  • By Type
    • Sensorineural Hearing Loss
    • Conductive Hearing Loss
  • By End User
    • Hospitals & Clinics
    • Home Settings
    • Ambulatory Surgical Centers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Sonova
  • Amplifon
  • IntriCon Corporation
  • Cochlear Ltd
  • GN Store Nord A/S
  • Knowles Electronics, LLC
  • Sivantos Pte. Ltd.
  • William Demant Holding A/S
  • MED-EL
  • Starkey

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: EUROPE EAR-BASED HEARING AIDS MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. In-The-Ear Aids

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Receiver-In-The-Ear Aids

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Behind-The-Ear Aids

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Canal Hearing Aids

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: EUROPE EAR-BASED HEARING AIDS MARKET, BY TECHNOLOGY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Technology

    • 5.2. Digital Hearing Aids

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Analog Hearing Aids

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: EUROPE EAR-BASED HEARING AIDS MARKET, BY TYPE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Type

    • 6.2. Sensorineural Hearing Loss

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Conductive Hearing Loss

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: EUROPE EAR-BASED HEARING AIDS MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Hospitals Clinics

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Home Settings

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Ambulatory Surgical Centers

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: EUROPE EAR-BASED HEARING AIDS MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Type

      • 8.2.3. Market Size and Forecast, By Technology

      • 8.2.4. Market Size and Forecast, By Type

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S.

        • 8.2.7.1 Market size and forecast, type

        • 8.2.7.2 Market size and forecast, technology

        • 8.2.7.3 Market size and forecast, type

        • 8.2.7.4 Market size and forecast, end user

      • 8.2.8. Canada

        • 8.2.8.1 Market size and forecast, type

        • 8.2.8.2 Market size and forecast, technology

        • 8.2.8.3 Market size and forecast, type

        • 8.2.8.4 Market size and forecast, end user

      • 8.2.9. Mexico

        • 8.2.9.1 Market size and forecast, type

        • 8.2.9.2 Market size and forecast, technology

        • 8.2.9.3 Market size and forecast, type

        • 8.2.9.4 Market size and forecast, end user

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Type

      • 8.3.3. Market Size and Forecast, By Technology

      • 8.3.4. Market Size and Forecast, By Type

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France

        • 8.3.7.1 Market size and forecast, type

        • 8.3.7.2 Market size and forecast, technology

        • 8.3.7.3 Market size and forecast, type

        • 8.3.7.4 Market size and forecast, end user

      • 8.3.8. Germany

        • 8.3.8.1 Market size and forecast, type

        • 8.3.8.2 Market size and forecast, technology

        • 8.3.8.3 Market size and forecast, type

        • 8.3.8.4 Market size and forecast, end user

      • 8.3.9. Italy

        • 8.3.9.1 Market size and forecast, type

        • 8.3.9.2 Market size and forecast, technology

        • 8.3.9.3 Market size and forecast, type

        • 8.3.9.4 Market size and forecast, end user

      • 8.3.10. Spain

        • 8.3.10.1 Market size and forecast, type

        • 8.3.10.2 Market size and forecast, technology

        • 8.3.10.3 Market size and forecast, type

        • 8.3.10.4 Market size and forecast, end user

      • 8.3.11. UK

        • 8.3.11.1 Market size and forecast, type

        • 8.3.11.2 Market size and forecast, technology

        • 8.3.11.3 Market size and forecast, type

        • 8.3.11.4 Market size and forecast, end user

      • 8.3.12. Russia

        • 8.3.12.1 Market size and forecast, type

        • 8.3.12.2 Market size and forecast, technology

        • 8.3.12.3 Market size and forecast, type

        • 8.3.12.4 Market size and forecast, end user

      • 8.3.13. Rest Of Europe

        • 8.3.13.1 Market size and forecast, type

        • 8.3.13.2 Market size and forecast, technology

        • 8.3.13.3 Market size and forecast, type

        • 8.3.13.4 Market size and forecast, end user

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Type

      • 8.4.3. Market Size and Forecast, By Technology

      • 8.4.4. Market Size and Forecast, By Type

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China

        • 8.4.7.1 Market size and forecast, type

        • 8.4.7.2 Market size and forecast, technology

        • 8.4.7.3 Market size and forecast, type

        • 8.4.7.4 Market size and forecast, end user

      • 8.4.8. Japan

        • 8.4.8.1 Market size and forecast, type

        • 8.4.8.2 Market size and forecast, technology

        • 8.4.8.3 Market size and forecast, type

        • 8.4.8.4 Market size and forecast, end user

      • 8.4.9. India

        • 8.4.9.1 Market size and forecast, type

        • 8.4.9.2 Market size and forecast, technology

        • 8.4.9.3 Market size and forecast, type

        • 8.4.9.4 Market size and forecast, end user

      • 8.4.10. South Korea

        • 8.4.10.1 Market size and forecast, type

        • 8.4.10.2 Market size and forecast, technology

        • 8.4.10.3 Market size and forecast, type

        • 8.4.10.4 Market size and forecast, end user

      • 8.4.11. Australia

        • 8.4.11.1 Market size and forecast, type

        • 8.4.11.2 Market size and forecast, technology

        • 8.4.11.3 Market size and forecast, type

        • 8.4.11.4 Market size and forecast, end user

      • 8.4.12. Thailand

        • 8.4.12.1 Market size and forecast, type

        • 8.4.12.2 Market size and forecast, technology

        • 8.4.12.3 Market size and forecast, type

        • 8.4.12.4 Market size and forecast, end user

      • 8.4.13. Malaysia

        • 8.4.13.1 Market size and forecast, type

        • 8.4.13.2 Market size and forecast, technology

        • 8.4.13.3 Market size and forecast, type

        • 8.4.13.4 Market size and forecast, end user

      • 8.4.14. Indonesia

        • 8.4.14.1 Market size and forecast, type

        • 8.4.14.2 Market size and forecast, technology

        • 8.4.14.3 Market size and forecast, type

        • 8.4.14.4 Market size and forecast, end user

      • 8.4.15. Rest of Asia Pacific

        • 8.4.15.1 Market size and forecast, type

        • 8.4.15.2 Market size and forecast, technology

        • 8.4.15.3 Market size and forecast, type

        • 8.4.15.4 Market size and forecast, end user

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Type

      • 8.5.3. Market Size and Forecast, By Technology

      • 8.5.4. Market Size and Forecast, By Type

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil

        • 8.5.7.1 Market size and forecast, type

        • 8.5.7.2 Market size and forecast, technology

        • 8.5.7.3 Market size and forecast, type

        • 8.5.7.4 Market size and forecast, end user

      • 8.5.8. South Africa

        • 8.5.8.1 Market size and forecast, type

        • 8.5.8.2 Market size and forecast, technology

        • 8.5.8.3 Market size and forecast, type

        • 8.5.8.4 Market size and forecast, end user

      • 8.5.9. Saudi Arabia

        • 8.5.9.1 Market size and forecast, type

        • 8.5.9.2 Market size and forecast, technology

        • 8.5.9.3 Market size and forecast, type

        • 8.5.9.4 Market size and forecast, end user

      • 8.5.10. UAE

        • 8.5.10.1 Market size and forecast, type

        • 8.5.10.2 Market size and forecast, technology

        • 8.5.10.3 Market size and forecast, type

        • 8.5.10.4 Market size and forecast, end user

      • 8.5.11. Argentina

        • 8.5.11.1 Market size and forecast, type

        • 8.5.11.2 Market size and forecast, technology

        • 8.5.11.3 Market size and forecast, type

        • 8.5.11.4 Market size and forecast, end user

      • 8.5.12. Rest of LAMEA

        • 8.5.12.1 Market size and forecast, type

        • 8.5.12.2 Market size and forecast, technology

        • 8.5.12.3 Market size and forecast, type

        • 8.5.12.4 Market size and forecast, end user

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Amplifon

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Cochlear Ltd

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. GN Store Nord A/S

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. IntriCon Corporation

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. MED-EL

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Sivantos Pte. Ltd.

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Sonova

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Starkey

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Knowles Electronics, LLC

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. William Demant Holding A/S

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL EUROPE EAR-BASED HEARING AIDS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. EUROPE EAR-BASED HEARING AIDS MARKET FOR IN-THE-EAR AIDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. EUROPE EAR-BASED HEARING AIDS MARKET FOR RECEIVER-IN-THE-EAR AIDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. EUROPE EAR-BASED HEARING AIDS MARKET FOR BEHIND-THE-EAR AIDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. EUROPE EAR-BASED HEARING AIDS MARKET FOR CANAL HEARING AIDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL EUROPE EAR-BASED HEARING AIDS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 7. EUROPE EAR-BASED HEARING AIDS MARKET FOR DIGITAL HEARING AIDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. EUROPE EAR-BASED HEARING AIDS MARKET FOR ANALOG HEARING AIDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL EUROPE EAR-BASED HEARING AIDS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 10. EUROPE EAR-BASED HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. EUROPE EAR-BASED HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL EUROPE EAR-BASED HEARING AIDS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 13. EUROPE EAR-BASED HEARING AIDS MARKET FOR HOSPITALS CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. EUROPE EAR-BASED HEARING AIDS MARKET FOR HOME SETTINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. EUROPE EAR-BASED HEARING AIDS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. EUROPE EAR-BASED HEARING AIDS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA EUROPE EAR-BASED HEARING AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 22. U.S. EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 23. U.S. EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 24. U.S. EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. U.S. EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. CANADA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. CANADA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 28. CANADA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. CANADA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. MEXICO EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. EUROPE EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE EUROPE EAR-BASED HEARING AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. GERMANY EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. ITALY EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 48. ITALY EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 49. ITALY EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. ITALY EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 52. SPAIN EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 53. SPAIN EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. SPAIN EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. UK EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. UK EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 57. UK EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. UK EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. RUSSIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. RUSSIA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 61. RUSSIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. RUSSIA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. REST OF EUROPE EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. REST OF EUROPE EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 65. REST OF EUROPE EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. REST OF EUROPE EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. ASIA-PACIFIC EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. ASIA-PACIFIC EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. ASIA-PACIFIC EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC EUROPE EAR-BASED HEARING AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 72. CHINA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 73. CHINA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 74. CHINA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. CHINA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. JAPAN EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 77. JAPAN EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 78. JAPAN EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 79. JAPAN EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. INDIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 81. INDIA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 82. INDIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 83. INDIA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH KOREA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH KOREA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. AUSTRALIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 89. AUSTRALIA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 90. AUSTRALIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 91. AUSTRALIA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. THAILAND EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 93. THAILAND EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 94. THAILAND EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 95. THAILAND EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. MALAYSIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 97. MALAYSIA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 98. MALAYSIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 99. MALAYSIA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. INDONESIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 101. INDONESIA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 102. INDONESIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 103. INDONESIA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. REST OF ASIA PACIFIC EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 105. REST OF ASIA PACIFIC EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 106. REST OF ASIA PACIFIC EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 107. REST OF ASIA PACIFIC EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. LAMEA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 109. LAMEA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 110. LAMEA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 111. LAMEA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA EUROPE EAR-BASED HEARING AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 113. BRAZIL EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 114. BRAZIL EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 115. BRAZIL EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 116. BRAZIL EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 117. SOUTH AFRICA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 118. SOUTH AFRICA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 119. SOUTH AFRICA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 120. SOUTH AFRICA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 121. SAUDI ARABIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 122. SAUDI ARABIA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 123. SAUDI ARABIA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 124. SAUDI ARABIA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. UAE EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 126. UAE EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 127. UAE EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 128. UAE EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 129. ARGENTINA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 130. ARGENTINA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 131. ARGENTINA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 132. ARGENTINA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 133. REST OF LAMEA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 134. REST OF LAMEA EUROPE EAR-BASED HEARING AIDS, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 135. REST OF LAMEA EUROPE EAR-BASED HEARING AIDS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 136. REST OF LAMEA EUROPE EAR-BASED HEARING AIDS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 137. AMPLIFON: KEY EXECUTIVES
  • TABLE 138. AMPLIFON: COMPANY SNAPSHOT
  • TABLE 139. AMPLIFON: OPERATING SEGMENTS
  • TABLE 140. AMPLIFON: PRODUCT PORTFOLIO
  • TABLE 141. AMPLIFON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. COCHLEAR LTD: KEY EXECUTIVES
  • TABLE 143. COCHLEAR LTD: COMPANY SNAPSHOT
  • TABLE 144. COCHLEAR LTD: OPERATING SEGMENTS
  • TABLE 145. COCHLEAR LTD: PRODUCT PORTFOLIO
  • TABLE 146. COCHLEAR LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. GN STORE NORD A/S: KEY EXECUTIVES
  • TABLE 148. GN STORE NORD A/S: COMPANY SNAPSHOT
  • TABLE 149. GN STORE NORD A/S: OPERATING SEGMENTS
  • TABLE 150. GN STORE NORD A/S: PRODUCT PORTFOLIO
  • TABLE 151. GN STORE NORD A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. INTRICON CORPORATION: KEY EXECUTIVES
  • TABLE 153. INTRICON CORPORATION: COMPANY SNAPSHOT
  • TABLE 154. INTRICON CORPORATION: OPERATING SEGMENTS
  • TABLE 155. INTRICON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 156. INTRICON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. MED-EL: KEY EXECUTIVES
  • TABLE 158. MED-EL: COMPANY SNAPSHOT
  • TABLE 159. MED-EL: OPERATING SEGMENTS
  • TABLE 160. MED-EL: PRODUCT PORTFOLIO
  • TABLE 161. MED-EL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. SIVANTOS PTE. LTD.: KEY EXECUTIVES
  • TABLE 163. SIVANTOS PTE. LTD.: COMPANY SNAPSHOT
  • TABLE 164. SIVANTOS PTE. LTD.: OPERATING SEGMENTS
  • TABLE 165. SIVANTOS PTE. LTD.: PRODUCT PORTFOLIO
  • TABLE 166. SIVANTOS PTE. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. SONOVA: KEY EXECUTIVES
  • TABLE 168. SONOVA: COMPANY SNAPSHOT
  • TABLE 169. SONOVA: OPERATING SEGMENTS
  • TABLE 170. SONOVA: PRODUCT PORTFOLIO
  • TABLE 171. SONOVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. STARKEY: KEY EXECUTIVES
  • TABLE 173. STARKEY: COMPANY SNAPSHOT
  • TABLE 174. STARKEY: OPERATING SEGMENTS
  • TABLE 175. STARKEY: PRODUCT PORTFOLIO
  • TABLE 176. STARKEY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. KNOWLES ELECTRONICS, LLC: KEY EXECUTIVES
  • TABLE 178. KNOWLES ELECTRONICS, LLC: COMPANY SNAPSHOT
  • TABLE 179. KNOWLES ELECTRONICS, LLC: OPERATING SEGMENTS
  • TABLE 180. KNOWLES ELECTRONICS, LLC: PRODUCT PORTFOLIO
  • TABLE 181. KNOWLES ELECTRONICS, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. WILLIAM DEMANT HOLDING A/S: KEY EXECUTIVES
  • TABLE 183. WILLIAM DEMANT HOLDING A/S: COMPANY SNAPSHOT
  • TABLE 184. WILLIAM DEMANT HOLDING A/S: OPERATING SEGMENTS
  • TABLE 185. WILLIAM DEMANT HOLDING A/S: PRODUCT PORTFOLIO
  • TABLE 186. WILLIAM DEMANT HOLDING A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL EUROPE EAR-BASED HEARING AIDS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL EUROPE EAR-BASED HEARING AIDS MARKET
  • FIGURE 3. SEGMENTATION EUROPE EAR-BASED HEARING AIDS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN EUROPE EAR-BASED HEARING AIDS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALEUROPE EAR-BASED HEARING AIDS MARKET
  • FIGURE 11. EUROPE EAR-BASED HEARING AIDS MARKET SEGMENTATION, BY TYPE
  • FIGURE 12. EUROPE EAR-BASED HEARING AIDS MARKET FOR IN-THE-EAR AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. EUROPE EAR-BASED HEARING AIDS MARKET FOR RECEIVER-IN-THE-EAR AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. EUROPE EAR-BASED HEARING AIDS MARKET FOR BEHIND-THE-EAR AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. EUROPE EAR-BASED HEARING AIDS MARKET FOR CANAL HEARING AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. EUROPE EAR-BASED HEARING AIDS MARKET SEGMENTATION, BY TECHNOLOGY
  • FIGURE 17. EUROPE EAR-BASED HEARING AIDS MARKET FOR DIGITAL HEARING AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. EUROPE EAR-BASED HEARING AIDS MARKET FOR ANALOG HEARING AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. EUROPE EAR-BASED HEARING AIDS MARKET SEGMENTATION, BY TYPE
  • FIGURE 20. EUROPE EAR-BASED HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. EUROPE EAR-BASED HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. EUROPE EAR-BASED HEARING AIDS MARKET SEGMENTATION, BY END USER
  • FIGURE 23. EUROPE EAR-BASED HEARING AIDS MARKET FOR HOSPITALS CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. EUROPE EAR-BASED HEARING AIDS MARKET FOR HOME SETTINGS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. EUROPE EAR-BASED HEARING AIDS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: EUROPE EAR-BASED HEARING AIDS MARKET
  • FIGURE 32. TOP PLAYER POSITIONING,2022
  • FIGURE 33. AMPLIFON: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. AMPLIFON: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. AMPLIFON: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. COCHLEAR LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. COCHLEAR LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. COCHLEAR LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. GN STORE NORD A/S: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. GN STORE NORD A/S: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. GN STORE NORD A/S: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. INTRICON CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. INTRICON CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. INTRICON CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. MED-EL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. MED-EL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. MED-EL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. SIVANTOS PTE. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. SIVANTOS PTE. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. SIVANTOS PTE. LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. SONOVA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. SONOVA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. SONOVA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. STARKEY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. STARKEY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. STARKEY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. KNOWLES ELECTRONICS, LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. KNOWLES ELECTRONICS, LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. KNOWLES ELECTRONICS, LLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. WILLIAM DEMANT HOLDING A/S: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. WILLIAM DEMANT HOLDING A/S: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. WILLIAM DEMANT HOLDING A/S: REVENUE SHARE, BY REGION, 2032 (%)

Purchase Full Report of
Europe Ear-Based Hearing Aids Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved